Senators to DEA: Consider Treaty Obligations In Marijuana Rescheduling
The FDA Law Blog
APRIL 22, 2024
Houck — Administrator Anne Milgram has been on the receiving end of high-level support for and against rescheduling marijuana since the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended the Drug Enforcement Administration (“DEA”) reschedule from schedule I to schedule III last August. By Larry K.
Let's personalize your content